NCT03987464

Brief Summary

The process of receiving a diagnosis of mild cognitive impairment (MCI) is recognized to induce behavioral responses that can be either adaptive or maladaptive. Five specific areas of concern have been identified, including: 1) failure to plan for future decline, decreased compliance and interaction with medical care providers, 3) decreased confidence and reduced social engagement, 4) increased physical limitations and 5) decreased medication compliance. In this pilot study, participants with MCI and their study partners will participate in behavioral interventions (primarily training workshops and classes) targeting each of these five areas of potential maladaptive behaviors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 17, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2021

Completed
Last Updated

February 25, 2022

Status Verified

February 1, 2022

Enrollment Period

2.1 years

First QC Date

June 12, 2019

Last Update Submit

February 23, 2022

Conditions

Keywords

Alzheimer's Diseasemaladaptivebehavior

Outcome Measures

Primary Outcomes (1)

  • Self-Efficacy; general self-efficacy scale (GSES)

    The general self-efficacy scale (GSES) is a ten-item scale. Scores range from 10-40, with higher scores indicating more self-efficacy.

    9 months

Secondary Outcomes (29)

  • Readiness to complete advance directives (ACPES)

    9 months

  • Motivations Around Advance Care Planning (ADS)

    9 months

  • Long Term Care Planning Behavior Scale (LTCP), planning subscale

    9 months

  • Long-Term Supports and Services (LTSS)

    9 months

  • World Health Organization Quality-of-Life (WHOQOL), Brief - Psychological and Social Relationship subscale

    9 months

  • +24 more secondary outcomes

Study Arms (1)

Patients with MCI

EXPERIMENTAL

Participants diagnosed with mild cognitive impairment (MCI) and their study partners

Behavioral: Planning for the FutureBehavioral: Enhanced Medical EngagementBehavioral: Confidence Building and Social EngagementBehavioral: Physical InterventionBehavioral: Medical Adherence

Interventions

This intervention will include attending an advance directives meeting, a living arrangements workshop, and a psychosocial education training workshop.

Patients with MCI

This intervention includes creating a health portfolio, health record access training, and a medical engagement workshop

Patients with MCI

This intervention includes mindfulness training, a pre-experience training techniques workshop and a memory strategies class.

Patients with MCI

This intervention includes physical/occupational therapy (PT/OT), a home safety assessment, and an independent exercise program.

Patients with MCI

This intervention includes using automated pillboxes to ensure medication compliance, optimizing appropriate medication use through review, and engaging with memory medications via class.

Patients with MCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • current subjects of the University of Kentucky Alzheimer's Disease Center (ADC)
  • meet consensus guidelines for mild cognitive impairment (MCI) developed by the Second International Working Group on MCI
  • have been diagnosed within the last year
  • able to provide informed consent
  • have a study partner willing to participate

You may not qualify if:

  • history of stroke
  • significant neurological or psychiatric conditions
  • brain injury
  • residence in institutional setting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseBehavior

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative Diseases

Study Officials

  • Allison Gibson, PhD, MSW

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 12, 2019

First Posted

June 17, 2019

Study Start

November 1, 2019

Primary Completion

December 14, 2021

Study Completion

December 14, 2021

Last Updated

February 25, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations